NHLBI DIR LAMPOON Study: Intentional Laceration of the Anterior Mitral Leaflet to Prevent Left Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve Implantation

计划入组 32 人 · 首次发布于 2017 年 1 月 9 日

A Phase 2 Open-label Pilot Study Evaluating MYK-461 in Subjects With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction

计划入组 21 人 · 首次发布于 2016 年 7 月 22 日

Surgical Treatment of the Patients With Restrictive Phenotype of the Hypertrophic Cardiomyopathy Without LVOT Obstruction

计划入组 50 人 · 首次发布于 2025 年 5 月 18 日

Left-Levophencynonate hydrochloride

Complex Urinary Tract Infections(Phaxiam)

biofilm inhibitors (urinary tract infection)

TRACT Therapeutics, Inc.

United States

AtriCure

United States

Oventus Medical Ltd

Cytokinetics Secures FDA Approval for MYQORZO, Breaking Bristol Myers Squibb's Monopoly in Hypertrophic Cardiomyopathy

Cytokinetics' Aficamten Shows Superior Cardiac Benefits Over Standard Treatment in Hypertrophic Cardiomyopathy

Sanofi Acquires Rights to Cytokinetics' Aficamten for Hypertrophic Cardiomyopathy in Greater China